Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-046263

Chief Accounting Officer sold 907 shares at $8.97 ($8,135)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-26 Sale : show line 1 in the form −907 $8.97 $8,135 1,925 D
Open-market sales · 907 sh · avg $8.97 · $8,135
Loading xslF345X05/ownership.xml…